DIA 19th Annual EuroMeeting

Track:
Track 05 R&D and Innovation (Track 05)

Day & Time:
March 27, 11:00AM - 12:30PM

Session Title:
EU Commission/ EFPIA Public-Private Initiative to Support Innovation - The Innovative Medicines Initiative

Session Chair(s):
Irene Norstedt
Head of Sector Innovative Medicines, Health Research, European Commission
European Commission
European Community

Ian Ragan
Director Research
Eli Lilly & Company
United Kingdom

Session Description:
This session will describe the current state of play of the Innovative Medicines Initiative. Speakers from the two main organisations proposing the public private partnership - the EC and EFPIA - will describe the aspirations of the project and how it will achieve its objectives. A speaker from the public sector, as the main research partner of the pharmaceutical industry in IMI, will describe their involvement while a patient representative will explain how IMI will address patient needs.

Presentation(s) & Speaker(s):
EU Commission’s Point of View
Irene Norstedt
Head of Sector Innovative Medicines, Health Research, European Commission
European Commission
European Community

EFPIA RDG’s Point of View
Ian Ragan
Director Research
Eli Lilly & Company
United Kingdom

Point of View from the Public Sector
Jacques Demotes-Mainard
Coordinator ECRIN Programme
INSERM
France

Patient’s Point of View
Alistair Newton
Secretary-General
European Federation of Neurological Associations
United Kingdom